FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2024
Voltar para busca
Dado oficial do USPTO
ACTOME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
08/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 44
Data de depósito
28/03/2022
Data de registro
12/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/09/2023
Última transação
12/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
27
Localização do titular
DE
Examinador
MONINGHOFF, KIM
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Actome GmbH
Representantes
Mark T. Vogelbacker Eckert Seamans Cherin & Mellott, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents for use in diagnosisother than for medical or veterinary use; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria for scientific and research use; biomolecule labelling kits comprising reagents for use in scientific research; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA)other than for medical or veterinary purposes; diagnostic reagents for in-vitro useother than for medical and veterinary purposes; biochemicals for in vitro and in vivo scientific use; biochemicalsprecursors for in vitro genetic engineering use; biochemicalspolypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; reagents for in-vitro laboratory useother than for medical or veterinary purposes; biochemicalsmonoclonal antibodies for in vitro scientific or research use; diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; diagnostic preparations for scientific or research use other than for medical use; chemicals for use in scientific researchother than medical or veterinary purposes
Classe 5
Indicatorspreparations for medical diagnosis; reactantspreparations for medical diagnosis; in vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for use in diagnostic tests for medical purposes; reagents for in-vitro laboratory use for medical diagnostic purposes; reagents for in-vitro laboratory use for veterinary diagnostic purposes
Classe 44
Medical analysis services for the diagnosis of cancer; medical analysis for the diagnosis and treatment of persons; medical RNA and DNA analysis for cancer diagnosis and prognosis; medical testing services relating to the diagnosis and treatment of disease
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/12/2023
FIMP
FINAL DISPOSITION PROCESSED
16/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/08/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
04/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
25/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/04/2023
RFNT
REFUSAL PROCESSED BY IB
05/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/03/2023
RFRR
REFUSAL PROCESSED BY MPU
13/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/01/2023
CNRT
NON-FINAL ACTION WRITTEN
18/01/2023
DOCK
ASSIGNED TO EXAMINER
12/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/07/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACTOME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.